Covered recipient · General Payments record
KRISTINA DANIELLE MANCINI
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$1,049.16
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $306.95 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $81.53 | 5 |
| Exact Sciences Corporation | $73.05 | 3 |
| CVRx Inc. | $48.85 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.58 | 1 |
| ABBVIE INC. | $17.99 | 1 |
| DEXCOM, INC. | $17.50 | 1 |
| GlaxoSmithKline, LLC. | $16.78 | 1 |
| SANOFI-AVENTIS U.S. LLC | $15.68 | 1 |
| Lilly USA, LLC | $14.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.99 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107583918 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $20.58 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086296214 | CMS |
| CVRx, Inc. | $26.79 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133235574 | CMS |
| CVRx, Inc. | $22.06 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133235576 | CMS |
| Dexcom, Inc. | $17.50 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153372787 | CMS |
| Exact Sciences Corporation | $21.38 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114443572 | CMS |
| Exact Sciences Corporation | $24.82 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114443576 | CMS |
| Exact Sciences Corporation | $26.85 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114443580 | CMS |
| GlaxoSmithKline, LLC. | $16.78 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116640906 | CMS |
| Lilly USA, LLC | $14.99 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135738142 | CMS |
| Novo Nordisk Inc | $17.70 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100535603 | CMS |
| Novo Nordisk Inc | $15.45 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100629388 | CMS |
| Novo Nordisk Inc | $13.22 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100389013 | CMS |
| Novo Nordisk Inc | $16.69 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100540606 | CMS |
| Novo Nordisk Inc | $18.47 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100439967 | CMS |
| SANOFI-AVENTIS U.S. LLC | $15.68 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139862362 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.